VALYSTR · Stock research
Listed on NYSE. What the market is pricing into Bio-Rad Laboratories, Inc. (BIO) in the Healthcare sector: implied growth, valuation scenarios, SEC-filed financials, and what has moved the stock.
Healthcare · Life Sciences Tools & Services · market value about $10.0B · P/E 46.9 · revenue $2.6B (as of 2026-11-04)
Opening the full page… All companies · Research guides · What a reverse DCF shows